Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Open-market sale 10% owner sold 5,000,000 shares at an average $5.01 ($25,059,900)
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 4 Open-market sale Director sold 1,109,644 shares at $6.09 ($6,757,732)
  7. 4 Open-market sale Director sold 1,109,644 shares at $6.09 ($6,757,732)
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 3 Insider Initial Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 30 · 584 filings